Clinical Trial Update: Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the efficacy, safety, and tolerability of multiple doses of Oshadi Icp (Oshadi oral insulin) in patients with Type 1 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Oshadi Icp

Snippet

Sponsor: Oshadi Drug Administration | Conditions: Diabetes Mellitus, Insulin-Dependent | Phase 2 | Status: COMPLETED